Digital Health

Adam Walker

GMP, Sepsis & 900k NHS Doses a Year

Host Adam Walker meets his namesake — Qualified Person, NHS pharmacist and Head of Development & Innovation at the North East and North Cumbria Medicines Manufacturing Centre. They cover Specials manufacturing, the new aseptic pathfinder hub gearing up for 150,000 chemotherapy and 750,000 IV antibiotic doses a year, the door-to-needle sepsis window, the personal loss driving the mission, and the Help Me GMP platform training the next generation.

Healthcare Systems

Scott Schliebner

DCTs, Patient-Centric Trials & 30 Years of Pharma Innovation

Today's guest is Scott Schliebner, who is a seasoned biopharma executive with nearly 30 years of experience spanning biotech, CROs and nonprofit life science organizations. He currently serves as CEO and founder of Ascent Biostrategies and previously has worked at Novatech and various other companies.

AI & Technology

Thibault Geoui

AI, Drug Discovery What Next Generation of Scientists Must Learn

Today's guest is Thibault Geoui, dr. Tebo z, host of the acclaimed Tech and Drugs podcast, and a driving force at the intersection of biotech innovation and digital transformation. His podcast has become a go-to platform for unpacking the future of pharma, where Thibault brings a rare blend of scientific insight and startup savvy.

AI & Technology

Poorya Amini

Protocol AI, 800k Clinical Trials & Why Pharma Does It Wrong

Today's guest is Poorya Amini, founder and CEO of Risklick A Swiss digital health company that's redefining how clinical trial protocols are designed Poorya's, journey spans veterinary medicine, a PhD in pharmacology. And hands-on experience managing trials at the University of Burn.

AI & Technology

Matt Veatch

Real World Data, Phenotypes & Why Precision Beats Big Data

Today's guest is Matt Veatch, co-founder and COO of Naviance, and a driving force behind the Real World Wednesday's podcast, a weekly forum that's shaping how we think about real world data and real world evidence.

AI & Technology

Dr. Daniel Fox

Research Deserts & Building CRPN to Fix Clinical Trial Access

Today's guest is Dr. Daniel Fox, who is the CEO of CRPN Central, and a leader in redefining clinical research through decentralized patient first platforms. With a background in medicine policy and digital innovation, Dr. Fox is building scalable ecosystems that restore trust and transparency in trials.

Leadership & Career

Jan Krikava

Docuply, Affordable QMS & Why Small Pharma Deserves Better Tools

Today's guest is Jan Krikava, co-founder and managing director of Docu Ply, a document automation platform purpose built for the pharmaceutical and healthcare sectors with a degree in software engineering and a background in enterprise.

Clinical Trials

Keith Berelowitz

PRxEngage, 35k Users in Month 1 & Why Patients Need North Star

Today's guest is Keith Berelowitz, who is the founder and CEO of PRX engage a platform designed to revolutionize how we engage and retain patients in clinical trials with over 20 years of experience in pharma and biotech research.

Patient Voice

Steve Sanghera

Inventus, Purpose-Built Devices & an Obsession Over Rivets

Today's guest is Steve Sanghera, who is the CEO of Inventus, a UK based innovator redefining how clinical trials are powered through secure provisioned mobile devices. With a background steeped in digital transformation, Steve leads Inventus in delivering smartphones and tablets.

Founders & MedTech

Wessam Sonbol

Delve Health & Why Clinical Trials Failed His Mother

Today's guest is Wessam Sonbol, CEO of Delve Health, a pioneering force in digital health and decentralized trials. Leading a groundbreaking platform that supports clinical research in 65+ languages, Wessam is revolutionizing patient access to clinical trials through innovative integration of wearables, telehealth, and AI-powered solutions.

AI & Technology

Anders Mortin

Triticon, Knowledge World & 25 Years of Accidental Pharma

Today's guest is Anders Mortin, who is a seasoned eClinical professional with over two decades of experience in clinical development processes and systems known for his strategic vision and leadership, Anders excels in managing cross-functional teams and driving innovative solutions.

AI & Technology

Matthew Mace

Study Connect, Why Pharma Needs MedTech Outsiders in Cardiology

Today's guest is Matthew Mace, who is redefining what leadership looks like at the cutting edge of clinical research on multiple fronts. Founder of Study Connect, Inc. Where he's on a mission to streamline scientific innovation through faster trials and smarter collaboration.

Founders & MedTech